Sidley Austin LLP advised Alphamab Oncology (HKEX: 9966) as the Hong Kong and U.S. legal adviser in its HK$1.83 billion (approximately US$234 million) initial public offering…
This content is for Standard 1 Year members only. LoginJoin Now
Author: Michael Patrini
…
This content is for Standard 1 Year members only. LoginJoin Now